CD4 and collagenous colitis: The pronounced differences between MAIT cells, CD4+ and CD8+ T cells between active collagenous colitis patients that respond to budesonide and budesonide non-responders indicate that separate immunological mechanisms could be present that might require different types of immunomodulating treatments.